KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non Operating Income: 2009-2017

Historic Non Operating Income for Jazz Pharmaceuticals (JAZZ) over the last 2 years, with Mar 2017 value amounting to -$1.5 million.

  • Jazz Pharmaceuticals' Non Operating Income fell 78.75% to -$1.5 million in Q1 2017 from the same period last year, while for Mar 2017 it was -$941,000, marking a year-over-year increase of 41.88%. This contributed to the annual value of $1.4 million for FY2015, which is 83.36% down from last year.
  • Jazz Pharmaceuticals' Non Operating Income amounted to -$1.5 million in Q1 2017, which was down 95.46% from -$749,000 recorded in Q3 2016.
  • Jazz Pharmaceuticals' Non Operating Income's 5-year high stood at $2.2 million during Q1 2015, with a 5-year trough of -$1.9 million in Q2 2015.
  • Moreover, its 3-year median value for Non Operating Income was -$819,000 (2016), whereas its average is -$226,714.
  • Examining YoY changes over the last 5 years, Jazz Pharmaceuticals' Non Operating Income showed a top increase of 23.34% in 2016 and a maximum decrease of 136.48% in 2016.
  • Jazz Pharmaceuticals' Non Operating Income (Quarterly) stood at $2.1 million in 2015, then climbed by 23.34% to -$749,000 in 2016, then tumbled by 78.75% to -$1.5 million in 2017.
  • Its last three reported values are -$1.5 million in Q1 2017, -$749,000 for Q3 2016, and -$819,000 during Q1 2016.